- Program Overview (5 mins)
- Updating My Practice Following San Francisco 2018 (25 mins)
- Summary of the most important studies on NAFLD/NASH
- Key practice recommendations for the clinic
- Question and Answer Session (15 mins)
Date / Time
Vlad Ratziu, MD, PhD
Department of Hepatology
Hospital Pitié Salpêtrière
Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF, FAASLD
Professor and Chairman
Department of Medicine
Inova Fairfax Medical Campus
Falls Church, Virginia
The goal of this activity is to improve participants’ competence in translating the most clinically important data from AASLD 2018 into practical management strategies for patients with liver diseases.
This program is intended for physicians, registered nurses, and other healthcare providers who care for patients with liver diseases.
Upon completion of this activity, participants should be able to:
- Integrate the results of recent clinical studies of NASH management strategies into clinical practice
- Implement new data on strategies for diagnosing and managing NASH now and in the future
- Incorporate the results of recent studies into the prevention and management of the clinical sequelae of advanced liver disease
Joint Accreditation Statement
In support of improving patient care, Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.7 contact hour.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.